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Abstract
AIM: To study the activation of pancreatic and pulmo-
nary mast cells and the effect of mast cell inhibition on 
the activation of peritoneal and alveolar macrophages 
during acute pancreatitis.
METHODS: Pancreatitis was induced by intraductal 
infusion of 5% sodium taurodeoxycholate in rats. The 
mast cell inhibitor cromolyn was administered intraperi-
toneally (i.p.) 30 min before pancreatitis induction. The 
pancreatic and pulmonary tissue damage was evaluated 
histologically and mast cells and their state of activation 
were evaluated. Peritoneal and alveolar macrophages 
were obtained and the expression of tumor necrosis 
factor α was determined. Myeloperoxidase activity was 
measured to evaluate the effect of mast cell inhibition 
on the progression of the inflammatory process. Finally, 
the effect of plasma on cultured mast cells or macro-
phages was evaluated in vitro .
RESULTS: The mast cell stabilizer significantly reduced 
inflammation in the pancreas and lung and the acti-
vation of alveolar macrophages but had no effect on 
peritoneal macrophages. Mast cell degranulation was 
observed in the pancreas during pancreatitis but no 
changes were observed in the lung. Plasma from rats 
with pancreatitis could activate alveolar macrophages 
but did not induce degranulation of mast cells in vitro .
CONCLUSION: Pancreatic mast cells play an important 
role in triggering the local and systemic inflammatory 
response in the early stages of acute pancreatitis. In 
contrast, lung mast cells are not directly involved in the 
inflammatory response related to pancreatic damage. 
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Acute pancreatitis represents a substantial clinical prob-
lem with increasing incidence and it is associated with 
high morbidity and mortality[1]. The most important 
predictor of  mortality is the development of  persistent 
or multiple organ failure and the commonest affected 
organ is the lung[2,3]. In these cases, acute lung injury is 
frequently related to early deaths in the first week of  the 
disease[4]. The mechanisms involved in triggering distant 
organ inflammation are unclear, however, in addition 
to the release of  activated hydrolytic enzymes, differ-
ent pathways have been reported, including cytokines[5], 
oxygen-derived free radicals[6] or activated complement[7].
Among these mechanisms, mast cells have been re-
ported to contribute to several aspects of  pancreatitis-
associated lung injury. These cells release a number of  
mediators, including histamine, tumor necrosis factor 
(TNF)α or monocyte chemotactic protein-1 (MCP-1) 
which could have a strong effect on pulmonary endothe-
lial cells, thus potentiating the progression of  inflamma-
tion[8,9]. The expression of  different adhesion molecules 
increases early after pancreatitis induction, and in some 
of  these molecules this increase could be prevented by 
administering mast cell degranulation inhibitors such as 
sodium cromolyn[10,11]. These observations suggest that 
masts cells are responding to mediators released during 
pancreatitis and, when activated, play a role in the induc-
tion of  endothelial lung dysfunction and in the progres-
sion of  the local and systemic inflammatory process.
Mast cells are usually located close to endothelial cells 
and this explains their effect on endothelial dysfunction 
when activated during pancreatitis. However, tissue-relat-
ed variability on the number, phenotype and distribution 
of  mast cell populations have been reported, resulting in 
different activation during inflammatory processes[12]. In 
the case of  acute pancreatitis, the use of  mast cell stabi-
lizers prevented changes in systemic inflammation and in 
endothelial permeability in different organs[10], however, 
the involvement of  the particular mast cell populations 
remains unclear. 
In this work we have evaluated the effect of  mast cell 
inhibition on the activation of  peritoneal and alveolar 
macrophages in an experimental model of  acute pancre-
atitis.
MATERIALS AND METHODS
Animal model of acute pancreatitis
Male Wistar rats (250-300 g b/w) (n = 6 each group) 
were anaesthetized with 10% urethane (1 mL/100 g, i.p.). 
The biliopancreatic duct was cannulated through the 
duodenum and the hepatic duct was closed by a small 
bulldog clamp. Severe acute pancreatitis was induced by 
retrograde infusion into the biliopancreatic duct of  5% 
sodium taurocholate (Sigma Chemical, St. Louis, MO, 
USA) in a volume of  0.1 mL/100 g b/w using a Harvard 
‘22’ infusion pump (Harvard Instruments, Edenbridge, 
UK)[13]. Control animals received an intraductal infusion 
of  saline solution (0.9% NaCl). In a group of  animals, 
cromolyn (Sigma, St Louis, MO, USA) (5 mg/kg b/w) 
was administered i.p. 30 min before pancreatitis induc-
tion. Three hours after induction, tissue samples of  
pancreas and lung were obtained, immediately frozen 
and maintained at -80℃ until processed. This time point 
was selected because we previously reported that, in this 
model, a significant systemic inflammation is initiated 
three hours after the induction of  pancreatitis[14]. Plasma 
samples were pelleted and the supernatant was stored at 
-40℃ until use. Pancreas and lung samples were also ob-
tained and stored for histological analysis. 
Histological analysis
Tissue samples were fixed in 10% neutral buffered for-
malin, embedded in paraplast, sectioned in 5 μm slices 
and stained with toluidine blue (0.1%). The dye was al-
lowed to dry on the slide for a few seconds; the slides 
were then rinsed in xylene for 5-10 min. and rinsed twice 
with acetone. Finally, the slides were cleared in xylene 
and mounted in diphenylphthalein xylene. Sections were 
evaluated by light microscopic examination.
Cell culture
Peritoneal macrophages were harvested by 5 peritoneal 
washes with 10 mL of  phosphate buffered saline (PBS) 
containing 3 units/mL heparin. The obtained cell sus-
pension was centrifuged (300 × g, 7 min). Cells were 
suspended in the RPMI1640 culture medium containing 
10% fetal calf  serum, 2 mmol/L glutamine, penicillin 
(100 U/mL) and streptomycin (100 μg/mL). Aliquots of  
about 3 × 106 cells were plated in 6 well plates and cul-
tured at 37℃ under a gas phase of  air/CO2 (95:5). After 
an attachment period of  4 h, the non-adhered cells were 
removed by shaking. The resulting adherent population 
consisted of  > 92% peritoneal macrophages.
Alveolar macrophages were obtained by bronchoal-
veolar wash. After exsanguinations, lung and trachea 
were excised en bloc and washed 5 times with 10 mL cold 
(4℃) saline solution. The supernatant was centrifuged 
at 300 × g for 7 min and the cells were resuspended in 
RPMI1640 culture medium containing 10% fetal calf  
serum, 2 mmol/L glutamine, penicillin (100 U/mL) and 
streptomycin (100 μg/mL). Aliquots of  about 3 × 106 
cells were plated in 6 well plates and cultured at 37℃ un-
3412 July 21, 2010|Volume 16|Issue 27|WJG|www.wjgnet.com
Lopez-Font I et al . Mast cells in pancreatitis
der a gas phase of  air/CO2 (95:5). After an attachment 
period of  4 h, the non-adhered cells were removed by 
shaking. The resulting adherent population consisted of  
> 95% alveolar macrophages.
The rat mast cell line RBL-2H3 was maintained as a 
monolayer culture in RPMI-1640 medium supplemented 
with 10% fetal calf  serum, penicillin (100 U/mL) and 
streptomycin (100 μg/mL) in an incubator with 5% CO2 at 
37℃. 
In vitro effect of plasma
The effects of  circulating mediators on mast cells or 
macrophages were evaluated by incubating alveolar mac-
rophages or the mast cell line RBL-2H3 with plasma 
obtained from controls, animals with pancreatitis or with 
cromolyn treated pancreatitis. Cells were cultured in 12 
well plates in the presence of  20% plasma in the culture 
media. One hour after culture at 37℃, the levels of  his-
tamine were measured in RBL-2H3 supernatants. For 
macrophages, RNA was obtained and the expression of  
TNFα was evaluated by quantitative real-time polymerase 
chain reaction (RT-PCR). 
RNA isolation and RT-PCR
Total RNA from cells was extracted using the TRizol® 
reagent (Invitrogen, Carlsbad, CA, USA). The RNA was 
quantified by measurement of  the absorbance at 260 and 
280 nm using a NanoDrop ND-1000 spectrophotom-
eter (NanoDrop Technologies, USA).
cDNA was synthesized using the iScript cDNA syn-
thesis kit (Bio-Rad Laboratories, Hercules, CA, USA), 
and reverse transcription was then performed on 1 μg 
RNA sample by adding iScript reagents. The reaction 
was incubated at 25℃ for 5 min, 42℃ for 30 min, and 
85℃ for 5 min, and then stored at -80℃. 
Subsequent PCR amplification was performed in a 
DNA Engine, Peltier Thermal Cycler (Bio-Rad Labo-
ratories, CA, USA) using IQTM SYBR Green Super 
mix and the correspondent rat primers: TNFα for-
ward: 5'-AACTCCCAGAAAAGCAAGCA-3' reverse: 
5'-CGAGCAGGAATGAGAAGAGG-3'; GAPDH for-
ward: 5'-CTGTGTCTTTCCGCTGTTTTC-3', reverse: 
5'-TGTGCTGTGCTTATGGTCTCA-3'. 
Initial denaturation was followed by 40 cycles of  DNA 
amplification with fluorescence detection at the end of  
the elongation step (SYBR Green format). Reactions were 
performed in duplicate and threshold cycle values were 
normalized to GAPDH gene expression. The specificity 
of  the products was determined by melting curve analy-
sis. The ratio of  the relative expression of  target genes to 
GAPDH was calculated by using the ΔC(t) formula.
Lipase
Plasma lipase was determined using commercial turbidi-
metric assay kits from Randox (Antrim, UK), according 
to the supplier’s specifications.
Histamine analysis
Histamine levels in plasma and in cell culture supernatants 
were evaluated using a commercial ELISA assay from La-
bor Diagnostika Nort (Nordhorn, Germany) according 
to the supplier’s specifications. 
TNFα
TNFα concentration in the cell culture medium was mea-
sured using a commercial kit for rat TNFα from BLK 
International (Badalona, Spain), according to the supplier’s 
specifications.
Myeloperoxidase
Neutrophilic infiltration was assessed by measuring myelo-
peroxidase (MPO) activity. MPO was determined photo-
metrically with 3,3’,5,5’-tetramethylbenzidine as substrate. 
Tissue samples were homogenized with 0.5% hexadecyltri-
methylammonium bromide in 50 mmol/L phosphate buf-
fer at pH 6.0. Homogenates were disrupted for 30 s using 
a Labsonic sonicator (Braun Biotech, Inc., Allentown, PA, 
USA) at 20% power and submitted to three cycles of  snap 
freezing in dry ice and thawing before a final 30 s sonica-
tion. Samples were incubated at 60℃ for 2 h and then 
spun down at 4000 × g for 12 min. The supernatants were 
collected for MPO assay. Enzyme activity was assessed 
photometrically using 630 nm wavelength. The assay mix-
ture consisted of  20 μL supernatant, 10 μL tetramethyl-
benzidine (final concentration 1.6 mmol/L) dissolved in 
DMSO, and 70 μL H2O2 (final concentration 3.0 mmol/L) 
diluted in 80 mmol/L phosphate buffer, pH 5.4. The re-
sults are expressed as units (U) MPO activity per g protein.
Protein measurement: Total protein concentration in 
homogenates was determined using a commercial kit 
from BioRad (Munich, Germany).
Statistical analysis
Data are expressed as mean ± SE. Means of  different 
groups were compared using a one-way analysis of  vari-
ance. Tukey’s multiple comparison test was performed to 
evaluate significant differences between groups. Differ-
ences were assumed to be significant when P < 0.05.
RESULTS
Mast cell activation during pancreatitis
Histological analysis revealed the presence of  mast cells in 
the interlobular areas of  control pancreas (Figure 1A) and 
a general pancreatic mast cell degranulation after induction 
of  pancreatitis (Figure 1B). This degranulation was prevent-
ed by cromolyn treatment (Figure 1C). In lungs, mast cells 
could also be observed (Figure 1D), however, no apparent 
degranulation was detected in histological samples of  the 
lung 3 h after induction of  pancreatitis (Figure 1E). Cromo-
lyn treatment had no effect on lung mast cells (Figure 1F).
Effects of mast cell inhibition
Pancreatitis resulted in increased levels of  circulating li-
pase and histamine in plasma as well as enhanced MPO 
activity in both pancreas and lung (Figure 2). The inhibi-
tion of  mast cell degranulation with cromolyn did not 
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Figure 1  Presence of mast cells in pancreas (A-C) and lung (D-F), in control (A and D). Three hours after induction of pancreatitis (B and E) and under cromolyn 
treatment (C and F). Degranulating mast cells were observed in the pancreas after pancreatitis induction (B). Cromolyn treatment prevented mast cell degranulation (C). 
In contrast, no evident degranulation was observed in lung after induction of pancreatitis. Toluidine blue, × 40.
A B C
D E F
7000
6000
5000
4000
3000
2000
1000
0
Li
pa
se
 (
U
/L
)
               C            AP                AP + cromolyn
a a 60
50
40
30
20
10
0
H
is
ta
m
in
 (
ng
/m
L)
               C            AP                AP + cromolyn
a
c
2.0
1.5
1.0
0.5
0.0
Pa
nc
re
as
 M
PO
 (
U
/m
g 
pr
ot
)
               C            AP                AP + cromolyn
a
a,c
4
3
2
1
0
Lu
ng
 M
PO
 (
U
/m
g 
pr
ot
)
               C            AP                AP + cromolyn
a
a,c
Figure 2  Effect of mast cell inhibitor, cromolyn. Three hours after pancreatitis induction, increased levels of lipase and histamine were detected in plasma. 
Cromolyn treatment had no effect on lipase, which is related to acinar cell damage, but prevented the increase in histamine. In tissue, leukocyte infiltration was 
evaluated by measuring myeloperoxidase (MPO) activity. Pancreatitis resulted in increased MPO activity in both pancreas and lung. Cromolyn treatment partially 
prevented these increases. aP < 0.05 vs C; cP < 0.05 vs AP. C: Control; AP: Acute pancreatitis.
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modify the lipase levels, but resulted in a reduction in 
pancreatic MPO activity, indicating that this treatment had 
no effect on acinar cell damage but reduced pancreatic 
inflammation. Inhibition of  the inflammatory process in 
lung was also observed. Nevertheless, these inhibitions did 
not achieve the control values and MPO activity remained 
significantly increased with respect to the control group in 
both pancreas and lung.
Changes in peritoneal and alveolar macrophages
Pancreatitis resulted in the induction of  TNFα expression 
in both peritoneal and alveolar macrophages (Figure 3). 
However, at this time point the activation observed in 
peritoneal macrophages was one order of  magnitude 
greater than that observed in alveolar macrophages. This 
was reflected in the release of  TNFα which only showed 
a significant increase in peritoneal macrophages after pan-
creatitis induction, while the increase observed in alveolar 
macrophages was not statistically significant (Figure 3). 
Inhibition of  mast cell degranulation had no effect on 
peritoneal macrophage activation, but completely prevent-
ed the increase observed in TNFα expression in alveolar 
macrophages. 
Effect of plasma on cultured mast cells and macrophages
Incubation of  the RBL-2H3 cell line with plasma obtained 
from animals with pancreatitis did not result in increased 
histamine release (Figure 4). In contrast, this plasma was 
able to induce the activation of  alveolar macrophages, 
reflected in an increase in the expression of  TNFα. This 
induction was not observed when plasma was obtained 
from animals treated with cromolyn (Figure 4).
DISCUSSION
The development of  systemic inflammation during the 
progression of  severe acute pancreatitis involves mul-
tiple pathways and cell systems. Among them, mast cells 
appear to play a pivotal role between the hydrolytic en-
zymes released by damaged pancreatic acinar cells and 
the stress-induced response mediated by free radicals 
and inflammatory mediators. 
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Figure 3  Both peritoneal and alveolar macrophages were activated after induction of pancreatitis, but the expression of tumor necrosis factor α mRNA in 
peritoneal macrophages was one order of magnitude higher than that observed in alveolar macrophages. Tumor necrosis factor (TNF)α release was induced 
in peritoneal cells, while in alveolar cells the observed increase was not statistically significant. Cromolyn treatment completely prevented the activation of alveolar 
macrophages. In contrast, peritoneal macrophages remained activated under cromolyn treatment. aP < 0.05 vs C; cP < 0.05 vs AP. C: Control; AP: Acute pancreatitis.
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Figure 4  The effect of plasma on cultured mast cell line RBL-2H3 and alveolar macrophages. Mast cells were not activated by plasma from animals with 
pancreatitis. In contrast, the expression of tumor necrosis factor (TNF)α in alveolar macrophages was induced by plasma from animals with pancreatitis. This 
induction was not observed when animals were treated with cromolyn. aP < 0.05 vs C; cP < 0.05 vs AP. C: Control; AP: Acute pancreatitis.
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In this sense, mast cells seem to play a role amplify-
ing the acute inflammatory response in different organs 
early after the onset of  pancreatitis. Several mediators 
known to be released by mast cells, including platelet 
activating factor (PAF), histamine or prostaglandin D2 
(PGD2), have been shown to be increased a few min-
utes after the induction of  pancreatitis in experimental 
models[15,16]. In addition, the administration of  mast cell 
inhibitors results in a reduction of  the local and sys-
temic inflammatory response and, in particular, prevents 
changes in endothelial cells and vascular permeability[10].
However, it is important to evaluate the particular role 
of  the different mast cell populations in this process, in 
order to design therapeutic strategies centered on these 
cells. Due to the rapid activation of  pancreatic mast cells 
in the onset of  pancreatitis, the obvious therapeutic target 
may be pulmonary mast cells that are suspected of  being 
activated in the later stages of  the disease. 
In the present study, we evaluated the degranulation 
of  mast cells in pancreas and lung and found a differ-
ent response during pancreatitis. Histological evaluation 
showed a clear and extensive degranulation of  mast cells 
located in pancreatic tissue (Figure 1B). As expected, this 
degranulation was prevented by cromolyn administration 
(Figure 1C). In contrast, no clear evidence of  mast cell 
degranulation was observed in lung tissue (Figure 1E).
This was a surprising result, taking into account that 
cromolyn administration resulted in a clear reduction in 
lung inflammation revealed by MPO activity and by a 
lower activation of  alveolar macrophages (Figure 3). In 
addition, these results are in line with other authors who 
reported on the critical role of  mast cells in the inflam-
matory response in lung during pancreatitis.
An explanation for this apparent contradictory result 
is an indirect effect of  pancreatic mast-cell derived me-
diators on distant organs. Activation of  mast cells results 
in the immediate release of  mediators that play a role in 
the activation of  circulating leukocytes as demonstrated 
by Zhao et al[11]. On the other hand, the progression of  
inflammation in pancreatic tissue is modified by cro-
molyn treatment (Figures 1 and 2). Consequently, it is 
suspected that the profile of  pro-inflammatory media-
tors released to the bloodstream by pancreatic tissue and 
their ability to induce lung endothelial dysfunction could 
be modified by pancreatic mast cell inhibition.
To evaluate this possibility we treated alveolar macro-
phages as well as the mast cell line RBL-2H3 in vitro with 
plasma obtain from the different experimental groups. 
Our results indicate that plasma from the pancreatitis-
induced group did not stimulate the production of  
significant amounts of  histamine in culture (Figure 4). 
This result suggests that while pancreatic damage could 
enhance the activation and degranulation of  mast cells in 
the pancreas a few minutes after pancreatitis induction[8], 
mediators present in plasma are not sufficient to activate 
these cells in distant organs.
However, plasma from pancreatitis animals was able 
to induce the activation of  macrophages in vitro, reflected 
in the increased expression of  TNFα. This effect was 
clearly reduced when animals were treated with cromolyn 
(Figure 4). Together, these results indicate that pancreatic 
mast cells play an important role in triggering the local and 
systemic inflammatory response in the early stages of  acute 
pancreatitis. In contrast, lung mast cells are not directly in-
volved in the inflammatory response related to pancreatic 
damage. The early activation reported in pancreatic mast 
cells may make the use of  these cells as a pharmacological 
target difficult due to the short therapeutic window. 
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